Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 11 Gliosarcoma 6 Glioblastoma 6 Central Nervous System Neoplasms 6 Brain Neoplasms 5 Rhabdomyosarcoma 2 Recurrence 2 Osteosarcoma 2 Gastrointestinal Stromal Tumors 2 Bone Neoplasms 2 Stomach Neoplasms 1 Sarcoma, Synovial 1 Sarcoma, Kaposi 1 Prostatic Neoplasms 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms 1 Liposarcoma 1 Leiomyosarcoma 1 Glioma 1 Digestive System Neoplasms 1 Chondrosarcoma 1 Astrocytoma 1 Advanced Solid Tumors 1

Interventions

Ifosfamide 5 Filgrastim 5 Doxorubicin 5 Gemcitabine 4 Docetaxel 4 Radiotherapy 3 Proton Therapy 3 Carboplatin 3 regorafenib 2 ivosidenib 2 enasidenib 2 belinostat 2 Sunitinib 2 Peripheral Blood Stem Cell Transplantation 2 Nivolumab 2 Immune Checkpoint Inhibitors 2 HhAntag691 2 Fluorouracil 2 Etoposide 2 Epirubicin 2 Cyclophosphamide 2 Cisplatin 2 Chemotherapy, Adjuvant 2 Celecoxib 2 Bevacizumab 2 venetoclax 1 toripalimab 1 temsirolimus 1 tazemetostat 1 tanespimycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Chondrosarcoma × Everolimus × Sarcoma × Clear all

NCT02008019 2017-08-07

CHONRAD

Centre Leon Berard

Phase 2 Suspended

Chondrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡